Matthew R. Plooster - 18 May 2022 Form 4 Insider Report for KEMPHARM, INC (ZVRA)

Role: Director
Signature: /s/ Timothy J. Sangiovanni, Attorney-in-Fact for Matthew R. Plooster
Issuer symbol: ZVRA
Transactions as of: 18 May 2022
Net transactions value: +$24,780
Form type: 4
Filing time: 18 May 2022, 19:01:34 UTC
Previous filing: 01 Dec 2021
Next filing: 30 Jun 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ZVRA	Common Stock	Purchase	$3,433	+695	+28%	$4.94	3,195	18 May 2022	Direct	F1
transaction	ZVRA	Common Stock	Purchase	$4,529	+915	+29%	$4.95	4,110	18 May 2022	Direct	F1
transaction	ZVRA	Common Stock	Purchase	$15,133	+3,051	+74%	$4.96	7,161	18 May 2022	Direct	F1
transaction	ZVRA	Common Stock	Purchase	$1,685	+339	+4.7%	$4.97	7,500	18 May 2022	Direct	F1
holding	ZVRA	Common Stock						69	18 May 2022	By TD Ameritrade Clearing Inc. Custodian FBO Matthew Ryan Plooster Roth IRA, as trustee
holding	ZVRA	Common Stock						1,532	18 May 2022	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Held jointly with spouse.